CSJA:FRA
CSL ADR
၃၀.၆၀ €
၀.၀၀%
(၀.၀၀) 1D
နို ၁၂, GMT+၁ ၂၀:၁၆:၃၉ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Mkt. cap
ဋေ ၉.၇၄ ထ
Avg. vol.
၀.၀၀
Volume
၀.၀၀
52-wk high
၄၃.၄၀ €
52-wk low
၁၂.၇၀ €
No. of employees
၃ သောင်း
Mkt. cap
ဋေ ၉.၇၄ ထ
Avg. vol.
၀.၀၀
Volume
၀.၀၀
52-wk high
၄၃.၄၀ €
52-wk low
၁၂.၇၀ €
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Medical Republic
·
ပြီးခဲ့သည့် ၂ နာရီ
Q fever vaccine stocks set to run dry
Kalkine
·
ပြီးခဲ့သည့် ၇ နာရီ
CSL Limited Buys Back 35,318 Shares on 12 November 2026 in On-Market Program
TheBull.com.au
·
ပြီးခဲ့သည့် ၁၁ နာရီ
CSL Shares At 52Wk Highs: Can The Rally Stretch To Sixth Months?
Kalkine
·
ပြီးခဲ့သည့် ၂ ရက်
CSL Limited Buys Back 44,235 Shares on 10 November 2026 Under $1.15 Billion Program
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees၂.၉ သောင်း
Founded၁၉၁၆
Headquartersမဲလ်ဘုန်းမြို့, ဝိတိုရိယ ပြည်နယ်, ဩစတြေးလျ
SectorHealth Care
Industry-
Websitecsl.com